InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.045

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$15 Immuron CEO Steven Lydeamore to present at The Watchlist 23 Apr 2024 9:17AM $0.100 $0.045 fallen by 55%
$15 Immuron to host Live Virtual Event 15 Apr 2024 10:34AM $0.105 $0.045 fallen by 57.14%
$15 Immuron Travelan sales continued strong growth 10 Apr 2024 9:00AM $0.110 $0.045 fallen by 59.09%
$15 Change in substantial holding 22 Mar 2024 8:24AM $0.099 $0.045 fallen by 54.55%
$15 Notice under section 708A 14 Mar 2024 10:53AM $0.110 $0.045 fallen by 59.09%
$15 Change of Director's Interest Notice (DP) 14 Mar 2024 10:45AM $0.110 $0.045 fallen by 59.09%
$15 Application for quotation of securities - IMC 14 Mar 2024 10:40AM $0.110 $0.045 fallen by 59.09%
$15 Immuron CEO, Steven Lydeamore to present at Coffee Microcaps 14 Mar 2024 8:25AM $0.110 $0.045 fallen by 59.09%
$15 Change in substantial holding 14 Mar 2024 8:20AM $0.110 $0.045 fallen by 59.09%
$15 Travelan to progress to Phase 3 Clinical Trials in the US 7 Mar 2024 10:03AM $0.066 $0.045 fallen by 31.82%
$15 Trading Halt 5 Mar 2024 9:28AM $0.066 $0.045 fallen by 31.82%
$15 Change in substantial holding 1 Mar 2024 8:22AM $0.072 $0.045 fallen by 37.50%
$15 Appendix 4D and Half Year Report 28 Feb 2024 1:25PM $0.070 $0.045 fallen by 35.71%
$15 Presentation to Australian Biologics Festival 2024 21 Feb 2024 8:36AM $0.073 $0.045 fallen by 38.36%
$15 Immuron achieves record Travelan sales 13 Feb 2024 9:43AM $0.076 $0.045 fallen by 40.79%
$15 Investor Webinar Presentation 8 Feb 2024 9:26AM $0.073 $0.045 fallen by 38.36%
$15 Immuron achieves record half yearly Travelan sales 16 Jan 2024 9:26AM $0.076 $0.045 fallen by 40.79%
$15 Immuron Clinical Trials Update 22 Dec 2023 3:24PM $0.079 $0.045 fallen by 43.04%
$15 First Patients Enrolled in Campylobacter Clinical Study 4 Dec 2023 4:27PM $0.081 $0.045 fallen by 44.44%
$15 Investor Webinar Presentation 28 Nov 2023 4:13PM $0.084 $0.045 fallen by 46.43%
$15 Change of Director's Interest Notice (PB) 24 Nov 2023 1:55PM $0.076 $0.045 fallen by 40.79%
$15 Notification regarding unquoted securities - IMC 24 Nov 2023 1:46PM $0.076 $0.045 fallen by 40.79%
$15 Amended Constitution 22 Nov 2023 5:41PM $0.080 $0.045 fallen by 43.75%
$15 Results of Annual General Meeting 21 Nov 2023 12:15PM $0.080 $0.045 fallen by 43.75%
$15 Presentation to Annual General Meeting 21 Nov 2023 8:30AM $0.078 $0.045 fallen by 42.31%

176 - 200 of 783 results

Page 8 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.